GE HealthCare, the upcoming standalone healthcare business from GE, has announced its new board of directors and the target spinoff date.
The spinoff, which was announced in July, is part of GE’s larger plan to spin off three, independent companies––GE HealthCare, GE Vernova and GE Aerospace. The company expects the spinoff of GE HealthCare to be completed the first week of January 2023.
The first board of directors for GE HealthCare includes H. Lawrence Culp, Jr., Chairman and CEO, GE, and CEO, GE Aerospace, who will serve as non-executive chairman of GE HealthCare. Peter Arduini, CEO of GE HealthCare, will also serve as a director. GE also plans to appoint eight additional directors:
- Peter J. Arduini, who will also serve as GE Healthcare’s president and CEO
- H. Lawrence Culp, Jr., who has has served as the chairman and CEO of GE since October 2018
- Rodney F. Hochman, MD, president and CEO of Providence, a Catholic not-for-profit health system, since 2016
- Lloyd W. Howell, Jr., CFO and treasurer of Booz Allen Hamilton Holding Company (“Booz Allen”)
- Risa Lavizzo-Mourey, MD,
- Catherine Lesjak
- Anne T. Madden
- Tomislav Mihaljevic, MD
- William J. Stromberg
- Phoebe L. Yang
“With this initial group of Directors, we have a highly qualified and capable Board that will enable GE HealthCare to hit the ground running,” Culp said in a statement. “The team is building significant momentum and targeting a spin-off during the first week of January, and having our Board in place represents a critical milestone on this path.”
GE HealthCare manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for medical imaging.